SILVER SPRING, Md., Jan. 28, 2021 -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery,...
Commercial launch of ViBone® Moldable, a next generation moldable cellular bone matrix product in the US. DEERFIELD, Ill., January 12, 2021 — Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine...
SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
SILVER SPRING, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Updated agreement expands availability of ViBone® Moldable, a next generation moldable cellular bone matrix product DEERFIELD, Ill. and Silver Spring, Md, Nov. 16, 2020 -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company...